At its most recent meeting on October 26, 2021, the Board of Trustees of the American Herbal Products Association (AHPA) considered several topics of interest to the AHPA membership and consistent with AHPA’s Mission to promote the responsible and sustainable commerce of herbal products to ensure that consumers have informed access to a wide variety of safe herbal goods.
Early this month, Amazon updated its policy for vendors of dietary supplements on the Amazon platform. Amazon has maintained such a policy since at least late 2018, and has amended the policy on several occasions in the interim.
AHPA is now accepting nominations for the 2022 AHPA Awards. The awards will be presented at the Annual AHPA Member Meeting March 9th.
The November 2021 AHPA Report includes: AHPA Webinar: AERs and Product Recalls, AHPA updates Proposition 65 hemp industry guidance following passage of California AB 45, AHPA expresses support for lawful marketing of NAC ; and more!
The American Herbal Products Association (AHPA) provided a letter of support to the World Anti-Doping Agency (WADA) following the September 14, 2021 announcement of WADA’s Executive Committee recommendation that a scientific review of cannabis (Cannabis sativa L.) will be undertaken by the agency in 2022.
The American Herbal Products Association (AHPA) on October 8, 2021, joined the Natural Products Association (NPA) and the Council for Responsible Nutrition (CRN) in calling on the Food and Drug Administration (FDA) to clarify that N-acetyl cysteine (NAC) is a lawful dietary ingredient.
AHPA has published an update to its Guidance on California Proposition 65 and Hemp Products to recognize the impact of the passage of California AB 45 Industrial hemp products, which was signed into law by Governor Gavin Newsome on October 6, 2021.
The United States District Court for the Southern District of New York last week entered summary judgment in favor of the United States Food and Drug Administration (FDA) in a suit filed in 2017 that sought to overturn FDA’s allowance for the GRAS self-affirmation process commonly used to document the safety of new food ingredients.
The Food and Drug Administration (FDA) has called on the U.S. Congress to pass legislation that would require mandatory product listing (MPL) for all dietary supplements in the United States.
2021 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.